Table 1.
Variable | Total | Insulin Independent | Insulin Dependent | P Valuea (Between Groups) |
---|---|---|---|---|
n, % | 34 | 10 (29.4) | 24 (70.6) | |
Preoperative clinical characteristics | ||||
Age, mean, SD | 39.3 (13.7) | 35.2 (14.4) | 41.0 (13.4) | 0.27 |
Age, y; n (%) | 0.58 | |||
<20 | 1 (2.9) | 0 (0) | 1 (4.2) | |
20–39 | 18 (52.9) | 7 (70.0) | 11 (45.8) | |
40–59 | 12 (35.3) | 2 (20.0) | 10 (41.7) | |
≥60 | 3 (8.8) | 1 (10.0) | 2 (8.3) | |
Sex, n (%) | 0.05 | |||
Female | 21 (61.8) | 9 (90.0) | 12 (50.0) | |
Male | 13 (38.2) | 1 (10.0) | 12 (50.0) | |
Race, n (%) | 0.51 | |||
White | 32 (94.1) | 9 (90.0) | 23 (95.8) | |
Hispanic | 1 (2.9) | 0 (0) | 1 (4.2) | |
Non-Hispanic black | 1 (2.9) | 1 (10.0) | 0 (0) | |
Baseline BMI, kg/m2; mean (SD) | 24.0 (3.5) | 23.0 (1.9) | 24.3 (3.9) | 0.32 |
Baseline BMI, kg/m2; n (%) | 0.31 | |||
<18.5 | 1 (2.9) | 0 (0) | 1 (4.2) | |
18.5–24.9 | 22 (64.7) | 9 (90.0) | 13 (54.2) | |
25–29.9 | 9 (26.5) | 1 (10.0) | 8 (33.3) | |
≥30 | 2 (5.9) | 0 (0) | 2 (8.3) | |
Baseline glycemic status, n (%) | <0.01 | |||
Normal | 17 (50.0) | 9 (90.0) | 8 (33.3) | |
Prediabetesb | 17 (50.0) | 1 (10.0) | 16 (66.7) | |
IFGc | 7 (20.6) | 0 (0) | 7 (29.2) | |
IGTd | 12 (35.3) | 0 (0) | 12 (50.0) | |
Category of increased riske | 7 (20.6) | 1 (10.0) | 6 (25.0) | |
Pancreatitis pain duration ≥ 3 years | 21 (61.7) | 6 (60.0) | 15 (62.5) | 1.00 |
Pancreatitis etiology, n (%) | 0.06 | |||
Alcoholic | 5 (14.7) | 0 (0) | 5 (20.8) | |
Genetic | 10 (29.4) | 1 (10.0) | 9 (37.5) | |
Divisum | 3 (8.8) | 1 (10.0) | 2 (8.3) | |
Traumatic | 1 (2.9) | 0 (0) | 1 (4.2) | |
Necrotizing | 0 (0) | 0 (0) | 0 (0) | |
Idiopathic | 15 (44.1) | 8 (80.0) | 7 (29.2) | |
Perioperative characteristics | ||||
Islet yield (IEq), median (IQR) | 437,030 | 727,137 | 293,990 | <0.01 |
(213,190; 775,970) | (446,572; 1,257,323) | (200,074; 587,060) |
Abbreviations: IQR, interquartile range; SD, standard deviation.
P values represent the difference between insulin-independent and insulin-dependent groups.
Participants can have >1 criterion for diagnosis in this category.
Defined as fasting glucose 100–125 mg/dL.
Defined as 2-hour glucose on OGTT 140–199 mg/dL.
Defined as HbA1c 5.7%–6.4%.